The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Review on Quality of Life Issues in Patients with Primary Brain Tumors
Open accessAbstract
Health-related quality of life (HRQOL) has become an important outcome measure in clinical trials in primary brain tumor (i.e., glioma) patients, because they have an incurable disease. HRQOL is assessed using self-reported, validated questionnaires, addressing physical, psychological, emotional, and social issues. In addition to generic HRQOL instruments, disease-specific questionnaires have been developed, including for brain tumor patients. For the analysis and interpretation of HRQOL measurements, low compliance and missing data are methodological challenges. HRQOL in glioma patients may be negatively affected by the disease itself as well as by side effects of treatment. But treatment with surgery, radiotherapy, and chemotherapy may improve patient functioning and HRQOL, in addition to extending survival. Although HRQOL has prognostic significance in brain tumor patients, it is not superior to well-known clinical parameters, such as age and performance status. In clinical practice, assessing HRQOL may be helpful in the communication between doctor and patient and may facilitate treatment decisions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Self-citationAaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Pelletier, G., Verhoef, M. J., Khatri, N., & Hagen, N. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015728825642 · Cited by 362
Cited by
Management of glioblastoma: State of the art and future directions
Tan, A. C., Ashley, D. M., López, G. Y., Malinzak, M., Friedman, H. S., & Khasraw, M. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21613 · Cited by 1,972
Soffietti, R., Kocher, M., Abacioglu, U. M., Villa, S., Fauchon, F., Baumert, B. G., Fariselli, L., Tzuk-Shina, T., Kortmann, R.-D., Carrie, C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0639 · Cited by 636
Self-citationSymptom management and quality of life in glioma patients
Boele, F. W., Klein, M., Reijneveld, J. C., Verdonck-de Leeuw, I. M., & Heimans, J. J. (2014) · CNS Oncology · doi:10.2217/cns.13.65 · Cited by 107
Moritz-Gasser, S., Herbet, G., Maldonado, I. L., & Duffau, H. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0789-9 · Cited by 99
Pan‐Weisz, T. M., Kryza‐Lacombe, M., Burkeen, J., Hattangadi‐Gluth, J., Malcarne, V. L., & McDonald, C. R. (2019) · Psycho-Oncology · doi:10.1002/pon.4906 · Cited by 32
Metadata
- Authors
- Taphoorn, M. J. B., Sizoo, E. M., & Bottomley, A.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05-27
- Volume
- 15
- Issue
- 6
- Pages
- 618-626
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2106825272
- Cited by
- 189
- References
- 3
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review on Quality of Life Issues in Patients with Primary Brain Tumors. https://app.cochat.ai/papers/10.1634/theoncologist.2009-0291
- The paper
- Taphoorn, M. J. B., Sizoo, E. M., & Bottomley, A. (2010). Review on Quality of Life Issues in Patients with Primary Brain Tumors. The Oncologist. https://doi.org/10.1634/theoncologist.2009-0291
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.